These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 20166879)

  • 21. Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.
    Oliveira VG; Caridade M; Paiva RS; Demengeot J; Graca L
    Eur J Immunol; 2011 May; 41(5):1249-55. PubMed ID: 21469093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
    Wang J; Huizinga TW; Toes RE
    J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-27 inhibits the development of regulatory T cells via STAT3.
    Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
    Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
    Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
    Lei J; Hasegawa H; Matsumoto T; Yasukawa M
    J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
    Yang Y; Paik JH; Cho D; Cho JA; Kim CW
    Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell suppression through an IL-2-related mechanism but independently of IL-10.
    Tenorio EP; Fernández J; Castellanos C; Olguín JE; Saavedra R
    Eur J Immunol; 2011 Dec; 41(12):3529-41. PubMed ID: 21905022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.
    Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC
    J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of regulatory T cells during experimental Leishmania infantum infection.
    Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM
    Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Zhao GJ; Lu ZQ; Tang LM; Wu ZS; Wang DW; Zheng JY; Qiu QM
    Int Immunopharmacol; 2012 Sep; 14(1):99-106. PubMed ID: 22749847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells.
    Gereke M; Jung S; Buer J; Bruder D
    Am J Respir Crit Care Med; 2009 Mar; 179(5):344-55. PubMed ID: 19096007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response.
    Sun L; Wu J; Yi S
    Transpl Immunol; 2012 Mar; 26(2-3):71-80. PubMed ID: 22079196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.